(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OTHAIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OTHAIR

ST13

US500000097039352

Class

5

Filing

97039352

Registration

8340295

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

07/14/2026

Trademark type

Word

Nice classes

5

Filing date

09/22/2021

Registration date

07/14/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/14/2026

Last transaction

07/14/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Dublin 2, IE

Examiner

MCBRIDE, CAMERON L

Law office

L60

Current location

INTENT TO USE SECTION

Holders and representatives

Holders

PROTHENA BIOSCIENCES LIMITED

Representatives

Jennifer L. Dean FAEGRE DRINKER BIDDLE & REATH LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of autoimmunemetastatichematologiconcologicocular and neurologic diseasesconditions and disorders; Biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of diseasesconditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of diseasesconditions and disorders affecting the central nervous system; Biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of amyloidosispsoriasispsoriatic arthritisrheumatoid arthritisdermatitishost and graft rejectionsAlzheimer's and Parkinson's-disease associated neuropsychiatric disordersinsulin resistancemetabolic syndrome and diabetes

Publications

History of USPTO decisions and trademark events.

41 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/14/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/14/2026

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

06/22/2026

IUCN

NOTICE OF ALLOWANCE CANCELLED

06/03/2026

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

06/03/2026

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/18/2026

EX5G

SOU EXTENSION 5 GRANTED

05/18/2026

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/15/2026

EEXT

SOU TEAS EXTENSION RECEIVED

12/16/2025

EXT5

SOU EXTENSION 5 FILED

12/15/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/18/2025

EX4G

SOU EXTENSION 4 GRANTED

06/17/2025

EXT4

SOU EXTENSION 4 FILED

06/17/2025

EEXT

SOU TEAS EXTENSION RECEIVED

06/17/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/03/2025

EX3G

SOU EXTENSION 3 GRANTED

12/18/2024

EXT3

SOU EXTENSION 3 FILED

12/18/2024

EEXT

SOU TEAS EXTENSION RECEIVED

12/18/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/13/2024

EX2G

SOU EXTENSION 2 GRANTED

06/10/2024

EXT2

SOU EXTENSION 2 FILED

06/10/2024

EEXT

SOU TEAS EXTENSION RECEIVED

06/09/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/21/2023

EX1G

SOU EXTENSION 1 GRANTED

12/19/2023

EXT1

SOU EXTENSION 1 FILED

12/19/2023

EEXT

SOU TEAS EXTENSION RECEIVED

12/19/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/20/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/25/2023

PUBO

PUBLISHED FOR OPPOSITION

04/25/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/05/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/20/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/03/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/03/2023

ALIE

ASSIGNED TO LIE

03/03/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/20/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/01/2022

GNRT

NON-FINAL ACTION E-MAILED

07/01/2022

CNRT

NON-FINAL ACTION WRITTEN

07/01/2022

DOCK

ASSIGNED TO EXAMINER

06/24/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/25/2021

NWAP

NEW APPLICATION ENTERED

09/25/2021

Continuous trademark protection

Get notified about every new filing that threatens OTHAIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.